![](/img/cover-not-exists.png)
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
Abouzayed, Ayman, Tano, Hanna, Nagy, Ãbel, Rinne, Sara S., Wadeea, Fadya, Kumar, Sharmishtaa, Westerlund, Kristina, Tolmachev, Vladimir, Eriksson Karlström, Amelie, Orlova, AnnaVolume:
12
Journal:
Pharmaceutics
DOI:
10.3390/pharmaceutics12100977
Date:
October, 2020
File:
PDF, 2.62 MB
2020